SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001593151-18-000005
Filing Date
2018-07-11
Accepted
2018-07-11 16:29:35
Documents
1
Effectiveness Date
2018-07-11
Items
Item 06b:
Item 4a5:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 14023
  Complete submission text file 0001593151-18-000005.txt   15106
Mailing Address 6 SOUTH STREET SUITE 203 MORRISTOWN NJ 07960
Business Address 6 SOUTH STREET SUITE 203 MORRISTOWN NJ 07960 862-260-9132
Cingulate Therapeutics (Filer) CIK: 0001593151 (see all company filings)

IRS No.: 461470260 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-316588 | Film No.: 18948950